Randomized, multi-center study comparing prolonged primary systemic endocrine therapy with letrozole alone or in combination with zoledronic acid in early breast cancer (NEOadjuvant Study in CANada).
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Letrozole (Primary) ; Zoledronic acid (Primary)
- Indications Early breast cancer
- Focus Biomarker; Therapeutic Use
- Sponsors Novartis
- 12 Nov 2008 Status changed from active, no longer recruiting to completed.
- 14 Oct 2008 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 07 Dec 2007 Status changed from recruiting to in progress.